Compare Crocs, Inc. (CROX) vs Herbalife Nutrition Ltd (HLF) Price & Performance

CROX trades at $115.20, down 4.18% amid bearish technical signals, though valuation metrics appear attractive with a P/E of 10.23 and P/S of 1.46. Recent earnings beats and a 51% analyst buy rating support fundamental strength, but 2025 net income turned negative due to tax impacts. The stock faces resistance near $116-119 with support at $114.

Outlook remains mixed: strong brand positioning and earnings momentum contrast with technical weakness and recent profitability challenges. The consensus price target of $136.78 suggests 19% upside, but investors should weigh competitive pressures and consumer spending volatility against valuation appeal.

Herbalife (HLF) trades at $12.65, up 0.56% with a bullish technical signal supported by moving averages. The company shows solid fundamentals with a low P/E of 8.11 and P/S of 0.26, though recent earnings have been mixed with two misses and one beat. A $250 million share repurchase program and CEO transition in October 2026 highlight ongoing corporate developments. Cash flow trends show improvement with projected positive net cash flow of $50 million in 2026.

HLF presents a value opportunity with discounted valuation metrics and analyst consensus target of $19.00 (50% upside). However, risks include negative shareholder equity, high debt levels, and inconsistent earnings performance. The stock offers potential for investors comfortable with turnaround execution risks in the wellness sector.